Related Experiment Videos
[Bioavailability of penicillin V in aqueous dosage forms]
Arzneimittel-Forschung
|January 1, 1984
Summary
Megacillin-oral-Trockensaft demonstrated superior bioavailability compared to another penicillin V potassium preparation. This leads to faster absorption, higher peak plasma concentrations, and potentially enhanced therapeutic efficacy and safety.
Area of Science:
- Pharmacokinetics
- Drug bioavailability
- Clinical pharmacology
Context:
- Comparison of oral drug formulations
- Penicillin V potassium (phenoxymethylpenicillin)
- Healthy volunteer studies
Purpose:
- Evaluate and compare the bioavailability of Megacillin-oral-Trockensaft versus another phenoxymethylpenicillin potassium salt preparation.
- Assess pharmacokinetic differences, including absorption rate, extent, and time to peak concentration.
- Determine the impact of bioavailability on the duration of therapeutic efficacy.
Summary:
- A cross-over study in 12 healthy volunteers compared Megacillin-oral-Trockensaft with another phenoxymethylpenicillin potassium salt preparation.
- Bioavailability was assessed using plasma concentrations (microbiological assay and HPLC), AUC, and time to maximum concentration.
- Megacillin-oral-Trockensaft showed significantly higher absorption rate and extent, resulting in 5-6 fold higher peak plasma concentrations reached faster.
Impact:
- Megacillin-oral-Trockensaft exhibits superior bioavailability, characterized by enhanced absorption and higher, faster-achieved plasma concentrations of phenoxymethylpenicillin.
- This improved pharmacokinetic profile suggests quicker therapeutic onset and potentially greater clinical safety due to prolonged effective drug levels.
- The findings support Megacillin-oral-Trockensaft as a more effective oral formulation of penicillin V potassium.